Factors Associated with Myelosuppression Related to Low-Dose Methotrexate Therapy for Inflammatory Rheumatic Diseases

• Shunsuke Mori ,

  * E-mail: moris@saisyunsou1.hosp.go.jp

  Affiliation Department of Rheumatology, Clinical Research Center for Rheumatic Diseases, NHO Kumamoto Saishunsou National Hospital, Kohshi, Kumamoto 861–1196, Japan

  ⨯
• Michihiro Hidaka,

  Affiliation Department of Hematology, NHO National Kumamoto Medical Center, Kumamoto 860–0008, Japan

  ⨯
• Toshiro Kawakita,

  Affiliation Department of Hematology, NHO National Kumamoto Medical Center, Kumamoto 860–0008, Japan

  ⨯
• Toshihiko Hidaka,

  Affiliation Institute of Rheumatology, Zenjinkai Shimin-no-Mori Hospital, Miyazaki 880–0122, Japan

  ⨯
• Hiroyuki Tsuda,

  Affiliation Department of Hematology and Oncology, Kumamoto City Hospital, Kumamoto 862–8505, Japan

  ⨯
• Tamami Yoshitama,

  Affiliation Yoshitama Clinic for Rheumatic Diseases, Kirishima, Kagoshima 899–5117, Japan

  ⨯
• Kiyoshi Migita,

  Affiliation Clinical Research Center, NHO National Nagasaki Medical Center, Omura, Nagasaki 856–8652, Japan

  ⨯
• Yukitaka Ueki

  Affiliation Rheumatic and Collagen Disease Center, Sasebo Chuo Hospital, Sasebo, Nagasaki 857–1195, Japan

  ⨯